QTTB
Q32 Bio Inc.
NASDAQ · USHealthcareBiotechnology
$15.04-0.07%
Price as of Jul 20, 2026
QTTB profitability
Q32 Bio Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 99.3%
- EBITDA margin
- 41.2%
- EBIT margin
- 39.8%
- Net margin
- 61.9%
- Free cash flow margin
- -51.0%
Returns
- Return on equity
- 71.8%
- Return on assets
- 52.2%
- Return on invested capital
- 35.7%
- Asset turnover
- 0.86x
Cash efficiency
- Cash from operations
- -$27.4M
- Cash per share
- $2.99
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.